» Articles » PMID: 39334877

The Antitumor Potential of Sicilian Grape Pomace Extract: A Balance Between ROS-Mediated Autophagy and Apoptosis

Abstract

From the perspective of circular economy, it is extremely useful to recycle waste products for human health applications. Among the health-beneficial properties of bioactive phyto-compounds, grape pomace represents a precious source of bioactive molecules with potential antitumor properties. Here, we describe the effects of a Sicilian grape pomace hydroalcoholic extract (HE) in colon and breast cancer cells. The characterization of HE composition revealed the predominance of anthoxanthins and phenolic acids. HE treatment was more effective in reducing the viability of colon cancer cells, while breast cancer cells appeared more resistant. Indeed, while colon cancer cells underwent apoptosis, as shown by DNA fragmentation, caspase-3 activation, and PARP1 degradation, breast cancer cells seemed to not undergo apoptosis. To elucidate the underlying mechanisms, reactive oxygen species (ROS) were evaluated. Interestingly, ROS increased in both cell lines but, while in colon cancer, cells' ROS rapidly increased and progressively diminished over time, in breast cancer, cells' ROS increase was persistent up to 24 h. This effect was correlated with the induction of pro-survival autophagy, demonstrated by autophagosomes formation, autophagic markers increase, and protection by the antioxidant NAC. The autophagy inhibitor bafilomycin A1 significantly increased the HE effects in breast cancer cells but not in colon cancer cells. Overall, our data provide evidence that HE efficacy in tumor cells depends on a balance between ROS-mediated autophagy and apoptosis. Therefore, inhibiting pro-survival autophagy may be a tool to target those cells that appear more resistant to the effect of HE.

Citing Articles

Nutrients and Nutraceuticals from L. Pomace: Biological Activities, Valorization, and Potential Applications.

Prata C, Zalambani C, Rossi F, Rossello S, Cerchiara T, Cappadone C Nutrients. 2025; 17(3).

PMID: 39940441 PMC: 11820150. DOI: 10.3390/nu17030583.

References
1.
Tuli H, Kaur J, Vashishth K, Sak K, Sharma U, Choudhary R . Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis. Arch Toxicol. 2022; 97(1):103-120. DOI: 10.1007/s00204-022-03421-z. View

2.
Hasnat H, Shompa S, Islam M, Alam S, Richi F, Emon N . Flavonoids: A treasure house of prospective pharmacological potentials. Heliyon. 2024; 10(6):e27533. PMC: 10944245. DOI: 10.1016/j.heliyon.2024.e27533. View

3.
Martinez-Inda B, Esparza I, Moler J, Jimenez-Moreno N, Ancin-Azpilicueta C . Valorization of agri-food waste through the extraction of bioactive molecules. Prediction of their sunscreen action. J Environ Manage. 2022; 325(Pt B):116460. DOI: 10.1016/j.jenvman.2022.116460. View

4.
Salerno L, Notaro A, Consoli V, Affranchi F, Pittala V, Sorrenti V . Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells. J Enzyme Inhib Med Chem. 2024; 39(1):2337191. PMC: 11028004. DOI: 10.1080/14756366.2024.2337191. View

5.
Lauricella M, DAnneo A, Giuliano M, Calvaruso G, Emanuele S, Vento R . Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb. Cell Death Differ. 2003; 10(8):930-2. DOI: 10.1038/sj.cdd.4401251. View